BACKGROUND: Approximately 15,000 new cases of myelodysplastic syndromes (MDS) are expected in the United States each year. METHODS: The mainstay for the management of myelodysplastic syndromes (MDS) is supportive therapy with red blood cell (RBC) transfusions to improve the patient’s quality... 

This information is about a group of conditions known as the myelodysplastic syndromes (MDS). They are a group of disorders affecting the bone marrow. They are not types of cancer, but can develop into leukaemia. However, the symptoms are often very similar to those caused by cancer, and the treatments... 

Myelodysplastic syndromes (MDS) are a group of diseases that cause immature blood cells (called blasts) to accumulate in the bone marrow leading to a shortage of mature blood cells, including red blood cells, white blood cells, and platelets. Furthermore, the mature blood cells that are made can also... 

Different types of treatments are available for patients with myelodysplastic syndromes. Some treatments are standard (the currently used treatment), and some are being tested in clinical trials. Before starting treatment, patients may want to think about taking part in a clinical trial. A treatment... 

Disease of bone marrow cells There are several subtypes of myelodysplastic syndromes (MDS), but they are all disorders in which the cells in the bone marrow don’t function normally and not enough normal blood cells are produced. MDS usually occurs in older people, typically starting after age 50.... 

Cancer Consultants provides summaries of new treatment strategies as they are discovered and reported by cancer physicians around the world. Our medical staff attends medical meetings worldwide and reviews medical literature daily to ensure appropriate news is provided to cancer patients and their families... 

Myelodysplastic syndrome (MDS) refers to a heterogeneous group of closely related clonal hematopoietic disorders. All are characterized by a hypercellular or hypocellular marrow with impaired morphology and maturation (dysmyelopoiesis) and peripheral blood cytopenias, resulting from ineffective blood... 

Myelodysplastic (myelo – bone marrow, dysplastic – abnormal growth) syndromes are a group of conditions caused by abnormal blood-forming cells of the bone marrow. In myelodysplastic syndromes (MDS), the bone marrow cannot produce blood cells effectively. Many of the blood cells formed are defective.... 

Myelodysplastic syndromes are diseases of the blood and bone marrow. Normally, the bone marrow produces stem cells (immature cells) that develop into mature blood cells. There are 3 types of mature blood cells: —      Red blood cells that carry oxygen and other materials to all tissues of the... 

Myelodysplastic syndromes (MDS) are a group of myeloid stem cell disorders that gradually affect the ability of a person’s bone marrow to produce normal cells such as red blood cells, white blood cells, and platelets. Patients with MDS have a risk of the disease progressing to acute myelogenous...